Vimarsana
Biggest News Aggregation in the World

Page 24 - Virtual Opioid Dependency Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Virtual Opioid Dependency Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Virtual Opioid Dependency Program Today - Breaking & Trending Today

A new weapon in the fight against opioid overdose - Vimarsana News

A new weapon in the fight against opioid overdose

Alberta’s government is the first in Canada to fully cover the cost of the injectable opioid treatment drug Sublocade. The treatment lasts in a person’s system for 30 days, providing stabilization, reduced craving and significantly enhanced protection against overdose.

Source: alberta.ca
Injectable drug to treat opioid addiction now fully funded in Alberta - Vimarsana News

Injectable drug to treat opioid addiction now fully funded in Alberta

On Wednesday, the Alberta government announced it will immediately begin fully funding Sublocade.

Source: cbc.ca
UCP surpasses targets in creating addictions treatment spaces, while still criticizing harm reduction - Vimarsana News

UCP surpasses targets in creating addictions treatment spaces, while still criticizing harm reduction

The UCP government in Alberta has funded more than 8,000 addiction treatment spaces in the last three years, doubling its 2019 target.

UCP surpasses target for new addictions treatment spaces - Vimarsana News

UCP surpasses target for new addictions treatment spaces

The UCP government in Alberta has funded more than 8,000 addiction treatment spaces in the last three years, doubling its 2019 target.

UCP surpasses targets in creating addictions treatment spaces, while still criticizing harm reduction - Vimarsana News

UCP surpasses targets in creating addictions treatment spaces, while still criticizing harm reduction

The UCP government in Alberta has funded more than 8,000 addiction treatment spaces in the last three years, doubling its 2019 target.